At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRCT PROCEPT BioRobotics
Post-Mkt 07-15 16:25:06 EDT
19.15
-0.16
-0.83%
盘后19.00
-0.15-0.78%
16:23 EDT
High19.34Low17.96Vol2.39M
Open19.10D1 Closing19.31Amplitude7.15%
Mkt Cap1.09BTradable Cap1.03BTotal Shares56.91M
T/O45.22MT/O Rate4.43%Tradable Shares53.95M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Mobia Medical Names Reza Zadno to Board as Independent Director
Reuters  ·  20 minutes ago
Mobia Medical Names Reza Zadno to Board as Independent Director
Mobia Medical Appoints Reza Zadno, Ph.d., to Its Board of Directors
THOMSON REUTERS  ·  21 minutes ago
Mobia Medical Appoints Reza Zadno, Ph.d., to Its Board of Directors
Procept Biorobotics to Report Q2 Results After Market Close, Host Conference Call
Reuters  ·  07-15 04:06
Procept Biorobotics to Report Q2 Results After Market Close, Host Conference Call
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
GlobeNewswire  ·  07-15 04:05
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)
TIPRANKS  ·  07-07
Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)
Procept Biorobotics Cut to Hold from Buy by Truist Securities
Dow Jones  ·  07-06
Procept Biorobotics Cut to Hold from Buy by Truist Securities
Procept Biorobotics Corp : Truist Securities Cuts to Hold from Buy; Cuts Target Price to $25 from $30
THOMSON REUTERS  ·  07-06
Procept Biorobotics Corp : Truist Securities Cuts to Hold from Buy; Cuts Target Price to $25 from $30
Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30
MT Newswires Live  ·  07-06
Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)
TIPRANKS  ·  07-03
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)
U.S. Research Roundup- Crowdstrike, Factset, Rivian
Reuters  ·  07-03
U.S. Research Roundup- Crowdstrike, Factset, Rivian
Procept Biorobotics Corp : Truist Securities Cuts to Hold from Buy; Cuts Target Price to $25 from $30
THOMSON REUTERS  ·  07-03
Procept Biorobotics Corp : Truist Securities Cuts to Hold from Buy; Cuts Target Price to $25 from $30
Procept BioRobotics downgraded to Hold from Buy at Truist
TIPRANKS  ·  07-03
Procept BioRobotics downgraded to Hold from Buy at Truist
Procept Biorobotics Posts Investor Presentation Outlining Aquablation Growth Strategy in BPH Market
Reuters  ·  06-30
Procept Biorobotics Posts Investor Presentation Outlining Aquablation Growth Strategy in BPH Market
Evercore ISI Initiates Coverage on PROCEPT BioRobotics With Outperform Rating, $30 Price Target
MT Newswires Live  ·  06-24
Evercore ISI Initiates Coverage on PROCEPT BioRobotics With Outperform Rating, $30 Price Target
Procept Biorobotics Initiated at Outperform by Evercore ISI Group
Dow Jones  ·  06-24
Procept Biorobotics Initiated at Outperform by Evercore ISI Group
Procept BioRobotics initiated with an Outperform at Evercore ISI
TIPRANKS  ·  06-24
Procept BioRobotics initiated with an Outperform at Evercore ISI
Procept Biorobotics Corp : Evercore Isi Initiates Coverage with Outperform Rating; Price Target $30
THOMSON REUTERS  ·  06-24
Procept Biorobotics Corp : Evercore Isi Initiates Coverage with Outperform Rating; Price Target $30
Analysts’ Top Healthcare Picks: PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PRME)
TIPRANKS  ·  06-23
Analysts’ Top Healthcare Picks: PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PRME)
PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?
Simply Wall St.  ·  06-23
PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?
PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds
Simply Wall St.  ·  06-20
PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds

Introduction

Company Name.
PROCEPT BioRobotics
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Issue price:
--